DRIO
DarioHealthยทNASDAQ
--
--(--)
--
--(--)
DRIO Profile
Dariohealth Corp.
A leading developer of medical devices and solutions to monitor blood glucose using smart phones
Healthcare Equipment and Supplies
08/11/2011
03/04/2016
NASDAQ Stock Exchange
196
12-31
Common stock
322 W. 57th St. #33B, New York, New York 10019
--
DarioHealth Corp. was incorporated on August 11, 2011 as a Delaware corporation. As a leading global digital health company, its core mission is to drive behavioral changes that drive better health. The company focuses on user engagement and provides personalized solutions through a self-developed whole-person health platform. Originally rooted in the direct-to-consumer (D2C) market and used as an innovation lab, it has expanded into the business-to-business (BB) segment, which now accounts for three-quarters of its revenue. Serving four key market segments, its clients include medium and large employers, health plans and global pharmaceutical companies. In 2024, the company has 53 employer clients, including the world's top technology companies and major employers in the United States, and the solution brings a good return on investment. Acquiring companies like Twill further strengthens its capabilities in chronic disease and mental health services.
